PPARGC1A
Peroxisome proliferator-activated receptor gamma coactivator 1-alpha
Also known as: PGC-1alpha, PGC1, PGC1A, PPARAGCIalpha, PPARGC1, PRGC1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9UBK2
- Gene
- PPARGC1A
- Ensembl
- ENSG00000109819
- Chromosome
- 4
- Canonical length
- 798 aa
- Protein class
- Cancer-related genes, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Cytosol
- Quaternary structure
- Homooligomer
OverviewNCBI Gene
The protein encoded by this gene is a transcriptional coactivator that regulates the genes involved in energy metabolism. This protein interacts with PPARgamma, which permits the interaction of this protein with multiple transcription factors. This protein can interact with, and regulate the activities of, cAMP response element binding protein (CREB) and nuclear respiratory factors (NRFs). It provides a direct link between external physiological stimuli and the regulation of mitochondrial biogenesis, and is a major factor that regulates muscle fiber type determination. This protein may be also involved in controlling blood pressure, regulating cellular cholesterol homoeostasis, and the development of obesity. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
798 residues, UniProt reviewed canonical sequence.
>Q9UBK2|PPARGC1A
1 MAWDMCNQDS ESVWSDIECA ALVGEDQPLC PDLPELDLSE LDVNDLDTDS FLGGLKWCSD
61 QSEIISNQYN NEPSNIFEKI DEENEANLLA VLTETLDSLP VDEDGLPSFD ALTDGDVTTD
121 NEASPSSMPD GTPPPQEAEE PSLLKKLLLA PANTQLSYNE CSGLSTQNHA NHNHRIRTNP
181 AIVKTENSWS NKAKSICQQQ KPQRRPCSEL LKYLTTNDDP PHTKPTENRN SSRDKCTSKK
241 KSHTQSQSQH LQAKPTTLSL PLTPESPNDP KGSPFENKTI ERTLSVELSG TAGLTPPTTP
301 PHKANQDNPF RASPKLKSSC KTVVPPPSKK PRYSESSGTQ GNNSTKKGPE QSELYAQLSK
361 SSVLTGGHEE RKTKRPSLRL FGDHDYCQSI NSKTEILINI SQELQDSRQL ENKDVSSDWQ
421 GQICSSTDSD QCYLRETLEA SKQVSPCSTR KQLQDQEIRA ELNKHFGHPS QAVFDDEADK
481 TGELRDSDFS NEQFSKLPMF INSGLAMDGL FDDSEDESDK LSYPWDGTQS YSLFNVSPSC
541 SSFNSPCRDS VSPPKSLFSQ RPQRMRSRSR SFSRHRSCSR SPYSRSRSRS PGSRSSSRSC
601 YYYESSHYRH RTHRNSPLYV RSRSRSPYSR RPRYDSYEEY QHERLKREEY RREYEKRESE
661 RAKQRERQRQ KAIEERRVIY VGKIRPDTTR TELRDRFEVF GEIEECTVNL RDDGDSYGFI
721 TYRYTCDAFA ALENGYTLRR SNETDFELYF CGRKQFFKSN YADLDSNSDD FDPASTKSKY
781 DSLDFDSLLK EAQRSLRRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PPARGC1A can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.63
- Highest tissue expression
- 42 nTPM
Expression across tissuesHPA
Tissue
- liver: 42 nTPM
- parathyroid gland: 36 nTPM
- tongue: 35 nTPM
- heart muscle: 34 nTPM
- skeletal muscle: 28 nTPM
- salivary gland: 28 nTPM
Single-cell type
- choroid plexus epithelial cells: 900 nCPM
- renal collecting duct intercalated cells: 813 nCPM
- distal convoluted tubule cells: 803 nCPM
- renal connecting tubule cells: 745 nCPM
- salivary duct cells: 714 nCPM
- loop of henle epithelial cells: 581 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- choroid plexus: 83 nTPM
- cerebral cortex: 38 nTPM
- hypothalamus: 33 nTPM
- cerebellum: 26 nTPM
- thalamus: 25 nTPM
- amygdala: 19 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.27
- gnomAD pLI
- 1
- gnomAD missense Z
- 1
- DepMap mean gene effect
- 0.08
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adipose tissue development
- brown fat cell differentiation
- cellular respiration
- cellular response to oxidative stress
- circadian regulation of gene expression
- digestion
- energy homeostasis
- fatty acid oxidation
- gluconeogenesis
- intracellular glucose homeostasis
- mitochondrion organization
- mRNA processing
- negative regulation of neuron apoptotic process
- negative regulation of smooth muscle cell proliferation
- neuron apoptotic process
- positive regulation of cold-induced thermogenesis
- positive regulation of DNA-templated transcription
- positive regulation of fatty acid oxidation
- positive regulation of gene expression
- positive regulation of gluconeogenesis
- positive regulation of transcription by RNA polymerase II
- protein stabilization
- protein-containing complex assembly
- regulation of circadian rhythm
- regulation of DNA-templated transcription
- respiratory electron transport chain
- response to dietary excess
- response to muscle activity
- response to starvation
- RNA splicing
- temperature homeostasis
- transcription initiation at RNA polymerase II promoter
Molecular functions
- chromatin DNA binding
- DNA binding
- DNA-binding transcription factor binding
- lncRNA binding
- nuclear receptor binding
- RNA binding
- RNA polymerase II-specific DNA-binding transcription factor binding
- sequence-specific DNA binding
- transcription coactivator activity
- transcription coregulator activity
- ubiquitin protein ligase binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PPARGC1A in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PPARGC1A as an antibody target. Whether an autoantibody or antibody against PPARGC1A could matter depends on whether native PPARGC1A is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PPARGC1A is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PPARGC1A as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...